150 related articles for article (PubMed ID: 15210577)
1. Regulation of metalloproteinases and NF-kappaB activation in rabbit synovial fibroblasts via E prostaglandins and Erk: contrasting effects of nabumetone and 6MNA.
Pillinger MH; Dinsell V; Apsel B; Tolani SN; Marjanovic N; Chan ES; Gomez P; Clancy R; Chang LF; Abramson SB
Br J Pharmacol; 2004 Jul; 142(6):973-82. PubMed ID: 15210577
[TBL] [Abstract][Full Text] [Related]
2. Predominant activation of MAP kinases and pro-destructive/pro-inflammatory features by TNF alpha in early-passage synovial fibroblasts via TNF receptor-1: failure of p38 inhibition to suppress matrix metalloproteinase-1 in rheumatoid arthritis.
Kunisch E; Gandesiri M; Fuhrmann R; Roth A; Winter R; Kinne RW
Ann Rheum Dis; 2007 Aug; 66(8):1043-51. PubMed ID: 17223661
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2-derived E prostaglandins down-regulate matrix metalloproteinase-1 expression in fibroblast-like synoviocytes via inhibition of extracellular signal-regulated kinase activation.
Pillinger MH; Rosenthal PB; Tolani SN; Apsel B; Dinsell V; Greenberg J; Chan ES; Gomez PF; Abramson SB
J Immunol; 2003 Dec; 171(11):6080-9. PubMed ID: 14634122
[TBL] [Abstract][Full Text] [Related]
4. The in vitro effects of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone, on rat gastric mucosal eicosanoid synthesis and metabolism.
Melarange R; Spangler R; Hoult JR
Prostaglandins Leukot Essent Fatty Acids; 1996 Sep; 55(3):195-200. PubMed ID: 8931119
[TBL] [Abstract][Full Text] [Related]
5. Resolution of inflammation: prostaglandin E2 dissociates nuclear trafficking of individual NF-kappaB subunits (p65, p50) in stimulated rheumatoid synovial fibroblasts.
Gomez PF; Pillinger MH; Attur M; Marjanovic N; Dave M; Park J; Bingham CO; Al-Mussawir H; Abramson SB
J Immunol; 2005 Nov; 175(10):6924-30. PubMed ID: 16272352
[TBL] [Abstract][Full Text] [Related]
6. Intercellular adhesion molecule-1 mediates the inhibitory effects of hyaluronan on interleukin-1beta-induced matrix metalloproteinase production in rheumatoid synovial fibroblasts via down-regulation of NF-kappaB and p38.
Hiramitsu T; Yasuda T; Ito H; Shimizu M; Julovi SM; Kakinuma T; Akiyoshi M; Yoshida M; Nakamura T
Rheumatology (Oxford); 2006 Jul; 45(7):824-32. PubMed ID: 16449361
[TBL] [Abstract][Full Text] [Related]
7. Annexin-1 mediates TNF-alpha-stimulated matrix metalloproteinase secretion from rheumatoid arthritis synovial fibroblasts.
Tagoe CE; Marjanovic N; Park JY; Chan ES; Abeles AM; Attur M; Abramson SB; Pillinger MH
J Immunol; 2008 Aug; 181(4):2813-20. PubMed ID: 18684973
[TBL] [Abstract][Full Text] [Related]
8. Kaempferol inhibits IL-1β-induced proliferation of rheumatoid arthritis synovial fibroblasts and the production of COX-2, PGE2 and MMPs.
Yoon HY; Lee EG; Lee H; Cho IJ; Choi YJ; Sung MS; Yoo HG; Yoo WH
Int J Mol Med; 2013 Oct; 32(4):971-7. PubMed ID: 23934131
[TBL] [Abstract][Full Text] [Related]
9. Effects of RWJ 67657, a p38 mitogen activated protein kinase (MAPK) inhibitor, on the production of inflammatory mediators by rheumatoid synovial fibroblasts.
Westra J; Limburg PC; de Boer P; van Rijswijk MH
Ann Rheum Dis; 2004 Nov; 63(11):1453-9. PubMed ID: 15479895
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6MNA (6-methoxy-2-naphthylacetic acid): comparison with indomethacin.
Melarange R; Gentry C; O'Connell C; Blower PR; Neil C; Kelvin AS; Toseland CD
Agents Actions; 1992; Spec No():C82-3. PubMed ID: 1442340
[TBL] [Abstract][Full Text] [Related]
11. Pro-inflammatory cytokine-induced matrix metalloproteinase-1 (MMP-1) secretion in human pancreatic periacinar myofibroblasts.
Tasaki K; Shintani Y; Saotome T; Andoh A; Fujiyama Y; Hozawa S; Bamba T
Pancreatology; 2003; 3(5):414-21. PubMed ID: 14526152
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase secretion by gastric epithelial cells is regulated by E prostaglandins and MAPKs.
Pillinger MH; Marjanovic N; Kim SY; Scher JU; Izmirly P; Tolani S; Dinsell V; Lee YC; Blaser MJ; Abramson SB
J Biol Chem; 2005 Mar; 280(11):9973-9. PubMed ID: 15640153
[TBL] [Abstract][Full Text] [Related]
13. Antiinflammatory and gastrointestinal effects of nabumetone or its active metabolite, 6-methoxy-2-naphthylacetic acid (6MNA). Comparative studies with indomethacin.
Melarange R; Gentry C; O'Connell C; Blower PR; Neil C; Kelvin AS; Toseland CD
Dig Dis Sci; 1992 Dec; 37(12):1847-52. PubMed ID: 1473433
[TBL] [Abstract][Full Text] [Related]
14. The effect of nabumetone and its principal active metabolite on in vitro human gastric mucosal prostanoid synthesis and platelet function.
Jeremy JY; Mikhailidis DP; Barradas MA; Kirk RM; Dandona P
Br J Rheumatol; 1990 Apr; 29(2):116-9. PubMed ID: 2108782
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide synthesis and its regulation by rabbit synoviocytes.
Stefanovic-Racic M; Stadler J; Georgescu HI; Evans CH
J Rheumatol; 1994 Oct; 21(10):1892-8. PubMed ID: 7837156
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-3 secretion from human pancreatic periacinar myofibroblasts in response to inflammatory mediators.
Inatomi O; Andoh A; Yagi Y; Ogawa A; Hata K; Shiomi H; Tani T; Takayanagi A; Shimizu N; Fujiyama Y
Pancreas; 2007 Jan; 34(1):126-32. PubMed ID: 17198194
[TBL] [Abstract][Full Text] [Related]
17. Disposition and excretion of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone in horses.
Soma LR; Uboh CE; Rudy JA; Smith MS
Am J Vet Res; 1996 Apr; 57(4):517-21. PubMed ID: 8712517
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 stimulates cytokines, prostaglandin E2 and matrix metalloproteinase-1 production via activation of MAPK/AP-1 and NF-kappaB in human gingival fibroblasts.
Kida Y; Kobayashi M; Suzuki T; Takeshita A; Okamatsu Y; Hanazawa S; Yasui T; Hasegawa K
Cytokine; 2005 Feb; 29(4):159-68. PubMed ID: 15652448
[TBL] [Abstract][Full Text] [Related]
19. Pyrrolidine dithiocarbamate, a NF-kappaB inhibitor, upregulates MMP-1 and MMP-13 in IL-1beta-stimulated rheumatoid arthritis fibroblast-like synoviocytes.
Kim KS; Oh DH; Choi HM; Bang JS; Ryu CJ; Kim JH; Yoo MC; Yang HI
Eur J Pharmacol; 2009 Jun; 613(1-3):167-75. PubMed ID: 19379726
[TBL] [Abstract][Full Text] [Related]
20. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway.
Birkenkamp KU; Tuyt LM; Lummen C; Wierenga AT; Kruijer W; Vellenga E
Br J Pharmacol; 2000 Sep; 131(1):99-107. PubMed ID: 10960075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
